In this Loeb Center Alumni-in-Residence session, Dr. Wendy Halpern ’88 will discuss her journey into biotechnology, including her experiences working toward developing treatment strategies for both humans and animals. She will also provide insight into how to step beyond the office to work to impact change at the national and international levels.
Dr. Wendy Halpern ’88 is a veterinary pathologist with more than 20 years of drug development experience. She earned her DVM from Ohio State University, where she also completed an M.S. in Veterinary Pathobiology, followed by a Ph.D. in Biomedical Sciences from the University of New Mexico. Drawn by the appeal of biotechnology, she joined Human Genome Sciences in 2000, and subsequently transitioned to Genentech as a Scientist and Veterinary Pathologist in 2007.
In addition to specific project support at Genentech, she actively contributes to the nonclinical strategy and safety assessment for pediatric drug development, with emphasis on challenges in pediatric oncology. She represents the Biotechnology Industry Organization (BIO) on an International Committee for Harmonisation (ICH) Working Group, which recently completed a new globally-harmonized, nonclinical safety guidance document for pediatric medicines (ICH S11). She has been an active member of the American College of Veterinary Pathology, the BioSafe group of BIO, the Birth Defects Research and Prevention Society, Safety Pharmacology Society, and the Society of Toxicologic Pathology.
This Alumni-in-Residence programming is presented by Amherst College's Loeb Center for Career Exploration and Planning. Learn more about the program here: https://www.amherst.edu/mm/575486